These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 11019931)

  • 1. Safety and tolerability considerations: tricyclic antidepressants vs. selective serotonin reuptake inhibitors.
    Peretti S; Judge R; Hindmarch I
    Acta Psychiatr Scand Suppl; 2000; 403():17-25. PubMed ID: 11019931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and tolerability of moclobemide in comparison with placebo, tricyclic antidepressants, and selective serotonin reuptake inhibitors in elderly depressed patients: a clinical overview.
    Amrein R; Stabl M; Henauer S; Affolter E; Jonkanski I
    Can J Psychiatry; 1997 Dec; 42(10):1043-50. PubMed ID: 9469236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SSRIS versus tricyclic antidepressants in depressed inpatients: a meta-analysis of efficacy and tolerability.
    Anderson IM
    Depress Anxiety; 1998; 7 Suppl 1():11-7. PubMed ID: 9597346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability.
    Anderson IM
    J Affect Disord; 2000 Apr; 58(1):19-36. PubMed ID: 10760555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of side effects of selective serotonin reuptake inhibitors and tricyclic antidepressants in older depressed patients: a meta-analysis.
    Wilson K; Mottram P
    Int J Geriatr Psychiatry; 2004 Aug; 19(8):754-62. PubMed ID: 15290699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. WITHDRAWN: Treatment discontinuation with selective serotonin reuptake inhibitors (SSRIs) versus tricyclic antidepressants (TCAs).
    Barbui C; Hotopf M; Freemantle N; Boynton J; Churchill R; Eccles MP; Geddes JR; Hardy R; Lewis G; Mason JM
    Cochrane Database Syst Rev; 2007 Jul; (3):CD002791. PubMed ID: 17636706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are SSRIs better than TCAs? Comparison of SSRIs and TCAs: a meta-analysis.
    Steffens DC; Krishnan KR; Helms MJ
    Depress Anxiety; 1997; 6(1):10-8. PubMed ID: 9394870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Side-effect profile of fluoxetine in comparison with other SSRIs, tricyclic and newer antidepressants: a meta-analysis of clinical trial data.
    Brambilla P; Cipriani A; Hotopf M; Barbui C
    Pharmacopsychiatry; 2005 Mar; 38(2):69-77. PubMed ID: 15744630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective serotonin reuptake inhibitors in the treatment of affective disorders--III. Tolerability, safety and pharmacoeconomics.
    Goldstein BJ; Goodnick PJ
    J Psychopharmacol; 1998; 12(3 Suppl B):S55-87. PubMed ID: 9808079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective serotonin reuptake inhibitors versus tricyclic antidepressants in young patients: a meta-analysis of efficacy and acceptability.
    Qin B; Zhang Y; Zhou X; Cheng P; Liu Y; Chen J; Fu Y; Luo Q; Xie P
    Clin Ther; 2014 Jul; 36(7):1087-1095.e4. PubMed ID: 24998011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The behavioural toxicity of the selective serotonin reuptake inhibitors.
    Hindmarch I
    Int Clin Psychopharmacol; 1995 Jan; 9 Suppl 4():13-7. PubMed ID: 7622818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative tolerability profiles of the newer versus older antidepressants.
    Rudorfer MV; Manji HK; Potter WZ
    Drug Saf; 1994 Jan; 10(1):18-46. PubMed ID: 8136085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of depression with associated anxiety: comparisons of tricyclic antidepressants and selective serotonin reuptake inhibitors.
    Montgomery SA; Judge R
    Acta Psychiatr Scand Suppl; 2000; 403():9-16. PubMed ID: 11019930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective serotonin reuptake inhibitors: meta-analysis of discontinuation rates.
    Montgomery SA; Henry J; McDonald G; Dinan T; Lader M; Hindmarch I; Clare A; Nutt D
    Int Clin Psychopharmacol; 1994; 9(1):47-53. PubMed ID: 8195583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and tolerability of milnacipran: an overview.
    Montgomery SA; Prost JF; Solles A; Briley M
    Int Clin Psychopharmacol; 1996 Sep; 11 Suppl 4():47-51. PubMed ID: 8923127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adverse effects associated with selective serotonin reuptake inhibitors and tricyclic antidepressants: a meta-analysis.
    Trindade E; Menon D; Topfer LA; Coloma C
    CMAJ; 1998 Nov; 159(10):1245-52. PubMed ID: 9861221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective serotonin reuptake inhibitors in older patients. A tolerability perspective.
    Skerritt U; Evans R; Montgomery SA
    Drugs Aging; 1997 Mar; 10(3):209-18. PubMed ID: 9108894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective serotonin reuptake inhibitors: a review of efficacy and tolerability in depression.
    Mace S; Taylor D
    Expert Opin Pharmacother; 2000 Jul; 1(5):917-33. PubMed ID: 11249500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of severe depression with the selective serotonin reuptake inhibitors.
    Schatzberg AF
    Depress Anxiety; 1996-1997; 4(4):182-9. PubMed ID: 9166650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tricyclic antidepressants for preventing migraine in adults.
    Xu XM; Liu Y; Dong MX; Zou DZ; Wei YD
    Medicine (Baltimore); 2017 Jun; 96(22):e6989. PubMed ID: 28562550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.